Z03.71

Z03.71: Encounter for suspected problem with amniotic cavity and membrane ruled out

Billable / specific codeICD-10-CMPOA exempt

Z03.71 is a billable, specific ICD-10-CM code for encounter for suspected problem with amniotic cavity and membrane ruled out. It is valid for submission on a claim.

Check Z03.71 with the rest of the claim: free scrubber

Inclusion terms

Alternative wordings a physician may use in the chart for this same code.

Encounter for suspected oligohydramnios ruled out
Encounter for suspected polyhydramnios ruled out

Excludes1 inherited from the categories above Z03.71

A category’s note binds every code beneath it.

Written on Z03.7: Encounter for suspected maternal and fetal conditions ruled out

known or suspected fetal anomalies affecting management of mother, not ruled out (O26.-, O35.-, O36.-, O40.-, O41.-)

Written on Z03: Encounter for medical observation for suspected diseases and conditions ruled out

contact with and (suspected) exposures hazardous to health (Z77.-)
encounter for observation and evaluation of newborn for suspected diseases and conditions ruled out (Z05.-)
person with feared complaint in whom no diagnosis is made (Z71.1)
signs or symptoms under study- code to signs or symptoms

Other codes that can never be billed with Z03.71

Their own Excludes1 notes name this code, so the conflict is not listed above.

Z01Encounter for other special examination without complaint, suspected or reported diagnosis
Z71.1Person with feared health complaint in whom no diagnosis is made

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Alphabetic index entries that lead here

Suspected condition, ruled out›amniotic cavity and membrane
Suspected condition, ruled out›oligohydramnios
Suspected condition, ruled out›polyhydramnios
Encounter›suspected condition, ruled out›amniotic cavity and membrane
Encounter›suspected condition, ruled out›oligohydramnios
Encounter›suspected condition, ruled out›polyhydramnios

Code history

Unchanged in every release from FY2024 to FY2027.